SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection

por Herat, Lakshini Y., Magno, Aaron L., Rudnicka, Caroline, Hricova, Jana, Carnagarin, Revathy, Ward, Natalie C., Arcambal, Angelique, Kiuchi, Marcio G., Head, Geoff A., Schlaich, Markus P., Matthews, Vance B.
Publicado 2020

Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis

por Al-Sharea, Annas, Lee, Man K. S., Whillas, Alexandra, Michell, Danielle L., Shihata, Waled A., Nicholls, Alyce J., Cooney, Olivia D., Kraakman, Michael J., Veiga, Camilla Bertuzzo, Jefferis, Ann-Maree, Jackson, Kristy, Nagareddy, Prabhakara R., Lambert, Gavin, Wong, Connie H. Y., Andrews, Karen L., Head, Geoff A., Chin-Dusting, Jaye, Murphy, Andrew J.
Publicado 2019